Following its report last year on Integrated care: organisations, partnerships and systems the Health and Social Care Committee has decided to scrutinise the legislative proposals put forward to support the implementation of the NHS Long-term Plan. Pre-legislative scrutiny of this kind aims to enhance the quality of legislation brought before …
The Department for Health and Social Care has recently published the findings of the review of the fit and proper persons test led by Tom Kark QC.
The Committee will hold a one-off session looking at the findings of the Kark report. As well as the author of the report, …
The Committee discussed progress in implementing the recommendations of the Committee's 2017 inquiry into suicide prevention with the Minister for Suicide Prevention Jackie Doyle-Price. Other stakeholders and relevant bodies also be participating in the session.
Further details of the Committee’s previous work in this area can be found here:
Health and harms:
Prevention and early intervention:
As the first part of a wider inquiry into the impact of drugs policy on public health, the Committee sought evidence on the usage of medicinal cannabis products. The Committee invited written submissions answering the following:
The Committee’s inquiry concentrated on the provision and pricing of Orkambi, and other drugs developed by Vertex Pharmaceuticals for the treatment of cystic fibrosis. The Committee considered the positions taken in the negotiations between Vertex and NHS England, and NICE’s assessment of the cost-effectiveness of these drugs.
Following the publication of the Draft Withdrawal Agreement and draft Political Declaration setting out the framework for the future relationship between the European Union and the United Kingdom, the Committee will question the Secretary of State, the CEO of NHS England Simon Stevens and officials from the Department of …
The Inquiry was announced on Thursday 15 November 2018. The Committee took oral evidence on Tuesday 20 November 2018; Tuesday 27 November 2018; Tuesday 15 January 2019; and Monday 28 January 2019. Further oral evidence sessions on the implementation of the NHS Long Term Plan are …
The Health and Social Care Committee will be holding an evidence session with the Chair and Chief Executive of the Care Quality Commission to discuss its annual State of Health and Adult Social Care Services report.
A full call for evidence is not being issued in connection with this session …
The Health and Social Care Committee will be holding an evidence session in October on the impact of a no-deal Brexit on health and social care.
Ahead of the session, the Committee is inviting written submissions from all interested parties, setting out: